Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Reperfusion Injury in STEMI Patients Undergoing pPCI
NCT03303378Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin in myocardial reperfusion injury (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: The salvage index at 3 months. Status: unknown.
02
Drugs
melatonin
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT03303378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303378.